• In the past week, Robert Half Inc. participated in the 2026 Baird Global Consumer, Technology & Services Conference and saw its shares advance alongside a broad rally in staffing and employment services peers, while its subsidiary Protiviti secured a second U.S. patent for AI-driven automated data set matching technology.
• This combination of sector-wide optimism and Protiviti’s new AI patent highlights how Robert Half’s consulting and technology capabilities may be increasingly important to its overall business mix.
• We’ll now examine how Protiviti’s new AI patent could shape Robert Half’s existing investment narrative around technology, margins, and growth.

AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Robert Half Investment Narrative Recap

To own Robert Half today, you need to believe that its mix of traditional staffing and higher value consulting can eventually offset recent revenue pressure and thin margins. The near term catalyst is improved demand for talent and consulting services, while the biggest risk remains revenue stagnation alongside rising SG&A and compressed profit margins. This week’s share move and Protiviti’s new AI patent are encouraging, but they do not materially change that core risk right now.

Among recent developments, Protiviti’s second U.S. patent for AI powered automated data set matching looks most relevant. It reinforces Robert Half’s push into proprietary AI tools, which could be important if technology enabled consulting and digital platforms become a bigger earnings driver than legacy staffing. For investors focused on catalysts, this patent may matter less for today’s numbers and more for whether Robert Half can reduce its exposure to more volatile, lower margin placement work over time.

Yet, while AI patents hint at upside, investors should also weigh how rising SG&A and weaker margins could limit the benefits of any eventual demand recovery...

Robert Half's narrative projects $5.9 billion revenue and $313.2 million earnings by 2028. This requires 1.9% yearly revenue growth and about a $135 million earnings increase from $178.1 million today.

Uncover how Robert Half's forecasts yield a $32.39 fair value, in line with its current price.

Exploring Other Perspectives

Some of the lowest analysts were assuming only about 2.2 percent annual revenue growth and US$220.7 million in earnings by 2029, so compared with the consensus narrative they paint a far more cautious picture that may or may not be softened by Protiviti’s new AI patent and the recent sector rally.

Explore 5 other fair value estimates on Robert Half - why the stock might be worth 21% less than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Robert Half research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Robert Half research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Robert Half's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 29 best rare earth metal stocks of the very few that mine this essential strategic resource.
• This technology could replace computers: discover 30 stocks that are working to make quantum computing a reality.
• Find 47 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.